Search

Supplemental material, sj-pdf-1-vmj-10.1177_1358863X221117607 for Trends, outcomes, and predictors of patients transferred with acute pulmonary embolism in the United States: Analysis of the Nationwide Inpatient Sample by Ahmed Elkaryoni, Islam Y Elgendy, Marwan Saad, David Luke, Islam Shatla, Sovik DeSirkar, Matthew C Bunte, J Dawn Abbott, Herbert D Aronow and Amir Darki in Vascular Medicine

Supplemental material, sj-pdf-1-vmj-10.1177_1358863X221117607 for Trends, outcomes, and predictors of patients transferred with acute pulmonary embolism in the United States: Analysis of the Nationwide Inpatient Sample by Ahmed Elkaryoni, Islam Y Elgendy, Marwan Saad, David Luke, Islam Shatla, Sovik DeSirkar, Matthew C Bunte, J Dawn Abbott, Herbert D Aronow and Amir Darki in Vascular Medicine

Supplemental material, sj-pdf-1-jet-10.1177_1526602820984111 for Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis by Michael I. Gurin, Sebastian E. Beyer, Mitchell Weinberg, Sahil A. Parikh, Ehrin J. Armstrong, Mazen S. Albaghdadi, Herbert D. Aronow, Brett J. Carroll, Robert Yeh and Eric A. Secemsky in Journal of Endovascular Therapy

Supplemental material, sj-pdf-1-vmj-10.1177_1358863X211021918 for North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative by Jun-Yang Lou, Kevin F Kennedy, Matthew T Menard, J Dawn Abbott, Eric A Secemsky, Philip P Goodney, Marwan Saad, Peter A Soukas, Omar N Hyder and Herbert D Aronow in Vascular Medicine

Supplemental material, sj-pdf-1-vmj-10.1177_1358863X211021918 for North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative by Jun-Yang Lou, Kevin F Kennedy, Matthew T Menard, J Dawn Abbott, Eric A Secemsky, Philip P Goodney, Marwan Saad, Peter A Soukas, Omar N Hyder and Herbert D Aronow in Vascular Medicine

Supplemental material, 19-0461_Supplementary_Figures for Presence of Contralateral Carotid Occlusion Is Associated With Increased Periprocedural Stroke Risk Following CEA but Not CAS: A Meta-analysis and Meta-regression Analysis of 43 Studies and 96,658 Patients by Damianos G. Kokkinidis, Nikos Chaitidis, Stefanos Giannopoulos, Pavlos Texakalidis, Moosa N. Haider, Herbert D. Aronow, Jay S. Giri and Ehrin J. Armstrong in Journal of Endovascular Therapy

Supplemental material, 19-0461_supplementary_tables for Presence of Contralateral Carotid Occlusion Is Associated With Increased Periprocedural Stroke Risk Following CEA but Not CAS: A Meta-analysis and Meta-regression Analysis of 43 Studies and 96,658 Patients by Damianos G. Kokkinidis, Nikos Chaitidis, Stefanos Giannopoulos, Pavlos Texakalidis, Moosa N. Haider, Herbert D. Aronow, Jay S. Giri and Ehrin J. Armstrong in Journal of Endovascular Therapy

OBJECTIVE: To assess peri-procedural bleeding complications in lower extremity peripheral vascular interventions (PVI). BACKGROUND: Few studies have examined the incidence, predictors, or outcomes of peri-procedural bleeding after lower extremity peripheral vascular intervention (PVI). METHODS: We studied patients undergoing PVI at 76 hospitals in the National Cardiovascular Data Registry (NCDR®) PVI registry™ from 2014 to 2016. Post-PVI major bleeding was defined as any overt bleeding with a hemoglobin (Hb) drop of ≥3 g/dl, any Hb decline of ≥4 g/dl or blood transfusion in patients with pre-procedure Hb >8 g/dl within 72 hours of their procedure. Hierarchical multivariable logistic regression was used to identify factors independently associated with post-PVI bleeding. We also examined adjusted in-hospital mortality among patients with or without major bleeding complications. RESULTS: Among 18,289 PVI procedures, major bleeding occurred in 744 (4.1%). Patient characteristics independently associated with bleeding included age, female sex, heart failure, pre-procedural hemoglobin

Supplemental material, 10.1177_1358863X18816816_supplemental_material_tables for Thirty-day readmission after endovascular or surgical revascularization for chronic mesenteric ischemia: Insights from the Nationwide Readmissions Database by Fabio V Lima, Dhaval Kolte, David W Louis, Kevin F Kennedy, J Dawn Abbott, Peter A Soukas, Omar N Hyder, Shafiq T Mamdani and Herbert D Aronow in Vascular Medicine

Supplemental material, 10.1177_1358863X19886374_Supplementary_material for Long-term mortality after massive, submassive, and low-risk pulmonary embolism by Rajesh Gupta, Zaid Ammari, Osama Dasa, Mohammed Ruzieh, Jordan J Burlen, Khaled M Shunnar, Hanh T Nguyen, Yanmei Xie, Pamela Brewster, Tian Chen, Herbert D Aronow and Christopher J Cooper in Vascular Medicine

Health literacy is the degree to which individuals are able to access and process basic health information and services and thereby participate in health-related decisions. Limited health literacy is highly prevalent in the United States and is strongly associated with patient morbidity, mortality, healthcare use, and costs. The objectives of this American Heart Association scientific statement are (1) to summarize the relevance of health literacy to cardiovascular health; (2) to present the adverse associations of health literacy with cardiovascular risk factors, conditions, and treatments; (3) to suggest strategies that address barriers imposed by limited health literacy on the management and prevention of cardiovascular disease; (4) to demonstrate the contributions of health literacy to health disparities, given its association with social determinants of health; and (5) to propose future directions for how health literacy can be integrated into the American Heart Association's mandate to advance cardiovascular treatment and research, thereby improving patient care and public health. Inadequate health literacy is a barrier to the American Heart Association meeting its 2020 Impact Goals, and this statement articulates the rationale to anticipate and address the adverse cardiovascular effects associated with health literacy.

ObjectivesThe purpose of this study was to compare health-related quality of life (HRQOL) outcomes in patients treated with carotid artery stenting (CAS) versus carotid endarterectomy (CEA).BackgroundIn CREST (Carotid Revascularization Endarterectomy versus Stenting Trial), the largest randomized trial of carotid revascularization to date, there was no significant difference in the primary composite endpoint, but rates of stroke and myocardial infarction (MI) differed between CAS and CEA. To help guide individualized clinical decision making, we compared HRQOL among patients enrolled in the CREST study. We also performed exploratory analyses to evaluate the association between periprocedural complications and HRQOL.MethodsWe measured HRQOL at baseline, and after 2 weeks, 1 month, and 1 year among 2,502 patients randomly assigned to either CAS or CEA in the CREST study. The HRQOL was assessed using the Medical Outcomes Study Short-Form 36 (SF-36) and 6 disease-specific scales designed to study HRQOL in patients undergoing carotid revascularization.ResultsAt both 2 weeks and 1 month, CAS patients had better outcomes for multiple components of the SF-36, with large differences for role physical function, pain, and the physical component summary scale (all p < 0.01). On the disease-specific scales, CAS patients reported less difficulty with driving, eating/swallowing, neck pain, and headaches but more difficulty with walking and leg pain (all p < 0.05). However, by 1 year, there were no differences in any HRQOL measure between CAS and CEA. In the exploratory analyses, periprocedural stroke was associated with poorer 1-year HRQOL across all SF-36 domains, but periprocedural MI or cranial nerve palsy were not.ConclusionsAmong patients undergoing carotid revascularization, CAS is associated with better HRQOL during the early recovery period as compared with CEA—particularly with regard to physical limitations and pain—but these differences diminish over time and are not evident after 1 year. Although CAS and CEA are associated with similar overall HRQOL at 1 year, event-specific analyses confirm that stroke has a greater and more sustained impact on HRQOL than MI. (Carotid Revascularization Endarterectomy versus Stenting Trial [CREST]; NCT00004732)